STATEMENT OF EARNINGS (UNAUDITED) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Net sales
Total revenues (Note 13)	$ 945.2	$ 927.1	$ 2,701.5	$ 2,762.2
Cost of sales
Total cost of sales	700.1	690.5	2,020.1	2,073.8
Gross profit	245.1	236.6	681.4	688.4
Selling and administrative expense	150.9	164.6	456.9	478.4
Research, development and engineering expense	20.3	23.4	65.3	69.7
Other operating income (loss)	0.1	2.2	(0.4)	(0.6)
Total costs and expenses	171.3	190.2	521.8	547.5
Operating profit	73.8	46.4	159.6	140.9
Other income (expense)
Interest income	2.1	2.9	6.1	10.1
Interest expense	(21.8)	(38.4)	(65.1)	(120.6)
Foreign exchange gain (loss), net	(0.8)	(2.9)	(41.5)	5.1
Miscellaneous gain (loss), net	(0.9)	1.7	3.2	5.3
Income before taxes	52.4	9.7	62.3	40.8
Income tax expense (Note 3)	9.6	29.9	12.2	58.8
Equity in loss of unconsolidated subsidiaries, net	(1.1)	(1.5)	(3.1)	(2.9)
Net income (loss)	41.7	(21.7)	47.0	(20.9)
Net income attributable to noncontrolling interests	0.6	0.7	2.0	1.2
Net income (loss) attributable to Diebold Nixdorf	$ 41.1	$ (22.4)	$ 45.0	$ (22.1)
Basic weighted-average shares outstanding (in shares)	36.5	37.6	37.1	37.6
Diluted weighted-average shares outstanding (in shares)	37.0	37.6	37.5	37.6
Net income (loss) attributable to Diebold Nixdorf
Basic earnings (loss) per share (in dollars per share)	$ 1.13	$ (0.60)	$ 1.21	$ (0.59)
Diluted earnings (loss) per share (in dollars per share)	$ 1.11	$ (0.60)	$ 1.20	$ (0.59)
Services
Net sales
Total revenues (Note 13)	$ 544.2	$ 541.7	$ 1,595.3	$ 1,607.2
Cost of sales
Total cost of sales	408.4	403.5	1,211.8	1,210.2
Products
Net sales
Total revenues (Note 13)	401.0	385.4	1,106.2	1,155.0
Cost of sales
Total cost of sales	$ 291.7	$ 287.0	$ 808.3	$ 863.6